ZURAMPIC

At a glance

Key dates

1. Approval

   FDA approval date of this drug product.

   Dec 22, 2015

   10 yr 8 mo ago

2. Today

3. Patent 10183012 expires

   Listed method-of-use patent (U-2311) expiration.

   Nov 26, 2028

   in 2 yr 6 mo

4. Patent 8283369 expires

   Listed method-of-use patent (U-1804) expiration.

   Nov 26, 2028

   in 2 yr 6 mo

5. Patent 8283369 expires

   Listed method-of-use patent (U-1802) expiration.

   Nov 26, 2028

   in 2 yr 6 mo

6. Patent 8546437 expires

   Listed method-of-use patent (U-1803) expiration.

   Apr 29, 2029

   in 2 yr 11 mo

7. Patent 8084483 expires

   Listed method-of-use patent (U-1801) expiration.

   Aug 17, 2029

   in 3 yr 3 mo

8. Patent 8357713 expires

   Listed drug product patent expiration.

   Dec 22, 2029

   in 3 yr 7 mo

9. Patent 8357713 expires

   Listed drug product patent expiration.

   Dec 22, 2029

   in 3 yr 7 mo

10. Patent 8357713 expires

    Listed drug product patent expiration.

    Dec 22, 2029

    in 3 yr 7 mo

11. Patent 9216179 expires

    Listed method-of-use patent (U-1806) expiration.

    Aug 01, 2031

    in 5 yr 2 mo

12. Patent 9956205 expires

    Listed method-of-use patent (U-2311) expiration.

    Dec 28, 2031

    in 5 yr 7 mo

13. Patent 8546436 expires

    Listed drug substance patent expiration.

    Feb 29, 2032

    in 5 yr 9 mo

Pharmaceutical detail

This is a reference-listed drug (RLD) — the basis for generic (ANDA) applications. Other products sharing this ingredient are listed below.

Listed patents (11)